ReviewCurrent oncology reports2026
Decoding Occult Cervical Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: From AI-Driven Multimodal Fusion to Clinical Translation.
Review in Current oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThis review examines the limitations of conventional macroscopic approaches in detecting occult cervical lymph node metastasis (OCLNM). It also explores how multi-omics technologies and artificial intelligence (AI) driven cross-scale multimodal integration are reshaping precision diagnosis for patients with clinically node-negative (cN0) head and neck squamous cell carcinoma. RECENT
findingsRecent studies show that combining high-throughput omics data, such as genome-wide DNA methylation and spatial transcriptomics, with radiomics through deep learning models leads to markedly better performance than conventional imaging alone. New computational strategies, including habitat radiomics and cross-modal fusion networks, allow more detailed characterization of spatial tumor heterogeneity. They also provide insights into how the tumor microenvironment evolves during early metastatic spread. In addition to improving detection of microscopic disease, these approaches are beginning to support more reliable survival risk stratification. The integration of AI with multi-omics data is moving the field toward a noninvasive "panoramic virtual biopsy." This framework offers a practical path to address a long-standing clinical challenge, balancing overtreatment against undertreatment in cN0 patients. With further validation, it may support safer surgical de-escalation and enable more personalized treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.